Term ends Nov 10, 2032 · High confidence
20-year base term ends Mar 5, 2029
Held by Eagle Pharmaceuticals, Inc.
Filed Mar 5, 2009 as application 12/380,968 · Granted Nov 10, 2015
Base term plus 1346 days of patent term adjustment (USPTO delay)
Today
2009
2032
Clock starts
Mar 5, 2009
Mar 5, 2009
Term ends
Nov 10, 2032
Nov 10, 2032
Granted
Nov 10, 2015
Nov 10, 2015
base term
patent term adjustment
fee events
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
1,346
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
7
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 1346 days past its 20-year base term on prosecution delay. 2 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Mar 5, 2009, when this application, 12/380,968, was filed | Mar 5, 2029 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +1346 days, USPTO patent term adjustment record | Nov 10, 2032 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Nov 10, 2032 | High confidence |
This family
| US 9,180,088 | this patent Nov 2032 | Nov 2032 |
| US 9,801,892 | In force Mar 2029 | Mar 2029 |
| US 10,363,259 | In force Mar 2029 | Mar 2029 |
| Application 16/508,741 | Abandoned not computed | not computed |
| Application 17/022,574 | Abandoned not computed | not computed |
| Application 17/819,726 | Abandoned not computed | not computed |
| Application 18/506,633 | Abandoned not computed | not computed |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Mar 5, 2009 Reel 22420, frame 691 | Palepu, Nageswara R. | Scidose LLC | Assignment of Assignor's Interest |
| Jun 2, 2016 Reel 38786, frame 619 | Scidose, LLC | Haz Two, LLC | Assignment of Assignor's Interest |
| Apr 27, 2018 Reel 45658, frame 54 | Haz Two, LLC | Eagle Pharmaceuticals, Inc. | Assignment of Assignor's Interest |
| Oct 24, 2022 Reel 61513, frame 804 | Eagle Pharmaceuticals, Inc. | JPMorgan Chase Bank, N.A., as Administrative Agent | Security Interest |
| Apr 1, 2025 Reel 70703, frame 524 | JPMorgan Chase Bank, N.A., as Administrative Agent | Eagle Pharmaceuticals, Inc. | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Nov 2032
Term ends Nov 10, 2032. Maintenance fees still fall due before then
Note
The 1346 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
17
later US patents cite this one
That is top 25% of utility patents granted in 2015 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.